ImmuCell Corp banner

ImmuCell Corp
NASDAQ:ICCC

Watchlist Manager
ImmuCell Corp Logo
ImmuCell Corp
NASDAQ:ICCC
Watchlist
Price: 7.54 USD -0.79%
Market Cap: $68.2m

ImmuCell Corp
Intangible Assets

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
|
See Also

ImmuCell Corp
Intangible Assets Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Intangible Assets CAGR 3Y CAGR 5Y CAGR 10Y
ImmuCell Corp
NASDAQ:ICCC
Intangible Assets
$4.8k
CAGR 3-Years
-57%
CAGR 5-Years
-46%
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Intangible Assets
$52.6B
CAGR 3-Years
-8%
CAGR 5-Years
-9%
CAGR 10-Years
10%
Gilead Sciences Inc
NASDAQ:GILD
Intangible Assets
$17B
CAGR 3-Years
-16%
CAGR 5-Years
-13%
CAGR 10-Years
5%
Amgen Inc
NASDAQ:AMGN
Intangible Assets
$22.3B
CAGR 3-Years
11%
CAGR 5-Years
6%
CAGR 10-Years
7%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Intangible Assets
$424.2m
CAGR 3-Years
-11%
CAGR 5-Years
1%
CAGR 10-Years
4%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Intangible Assets
$1.3B
CAGR 3-Years
11%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

ImmuCell Corp
Glance View

Market Cap
68.2m USD
Industry
Biotechnology

ImmuCell Corp. engages in the development, acquisition, manufacture and sale of products that improve the health and productivity of cows for the dairy and beef industries. The company is headquartered in Portland, Maine and currently employs 60 full-time employees. The firm is engaged in development, acquisition, manufacture and sale of products that improve the health and productivity of dairy and beef cattle. The company manufactures and markets the First Defense product line for the prevention of scours in newborn dairy and beef calves. The company expanded this line into five different products with formulations targeting E. coli and coronavirus pathogens, as well as E. coli, coronavirus and rotavirus pathogens. Its Tri-Shield First Defense product line extension is calf-level, passive antibody product providing immediate immunity against E. coli, coronavirus and rotavirus. These product line provides Immediate Immunity to newborn calves. The firm is engaged in development of Re-Tain, a Nisin treatment for subclinical mastitis in lactating dairy cows. Its products reduce the use of traditional antibiotics in food producing animals.

ICCC Intrinsic Value
4.99 USD
Overvaluation 34%
Intrinsic Value
Price $7.54

See Also

What is ImmuCell Corp's Intangible Assets?
Intangible Assets
4.8k USD

Based on the financial report for Dec 31, 2025, ImmuCell Corp's Intangible Assets amounts to 4.8k USD.

What is ImmuCell Corp's Intangible Assets growth rate?
Intangible Assets CAGR 5Y
-46%

Over the last year, the Intangible Assets growth was -75%. The average annual Intangible Assets growth rates for ImmuCell Corp have been -57% over the past three years , -46% over the past five years .

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett